American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington. DC: APA.
Black, D. W.
et al (1993) A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Archives of General Psychiatry, 50, 44–50.
Cassano, G. B.
et al (1994) Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. Europea. Neuropsychopharmacology, 4, 47–53.
Den-Boer, J. A.
Westenberg, H. G.
De Leeuw, A. S.
et al (1995) Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. International Clinical Psychopharmacology, 4, 47–52.
Greist, J. H.
et al (1995) Double-blind parallel comparison of three doses of sertraline and placebo in outpatients with obsessive compulsive disorder. Archives of General Psychiatry, 52, 289–295.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub (ADM). Rockville, MD: National Institute for Mental Health.
Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social Clinical Psychology, 6, 278–296.
McLeod, D. R. & Hipsley, P. A. (1993) Effect of fluvoxamine on panic disorder. Journal of Clinical Psychopharmacology, 13, 321–326.
Louie, A. K.
Lewis, T. B. & Lannon, R. A. (1993) Use of low-dose fluoxetine in major depression and panic disorder. Journal of Clinical Psychiatry, 54, 435–438.
Nagy, L. M.
Morgan, C. A. III
Southwick, S. M.
et al (1993) Open prospective trial of fluoxetine for posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 13, 107–113.
Noyes, R. Jr
Garvey, M. J.
Cook, B. L.
et al (1989) Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. Journal of Clinical Psychiatry, 50, 63–69.
Christiansen, P. E.
et al (1995) Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. British Journal of Psychiatry, 167, 374–379.
Pecknold, J. C. (1993) Discontinuation reactions to alprazolam in panic disorder. Conference on Panic and Anxiety: A Decade of Progress (1990, Geneva. Switzerland). Journal of Psychiatric Research, 27 (suppl. 1), 155–170.
Pecknold, J. C.
et al (1995) Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study. Psychiatry Neuroscience, 20, 193–198.
Pounds, R. (1992) A review of the medical and social consequences of generalized anxiety disorder and panic disorder. Journal of the Louisiana State Medical Society, 144, 479–483.
Rosenberg, R. (1993) Drug treatment of panic disorder. Pharmacology and Toxicology, 72, 344–353.
Salzman, C. (1993) Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse (Review). Journal of Psychiatric Research, 27 (suppl. 1), 97–100.
Sheehan, D. V. (1989) Diagnosis and psychiatry: examination of the psychiatric patient. In Comprehensive Textbook of Psychiatry (5th edn) (eds Kaplan, H. I. & Sadock, B. J.). Baltimore, MD: Williams and Wilkins.
Spitzer, R. L.
Williams, J. B. W.
et al (1990) Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press.
Cameron, A. & Levander, S. (1990) Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side-effects. Journal of Clinical Psychiatry, 51 (suppl.). 14–17, 50–53.
et al (1997) The effect of citalopram in panic disorder. British Journol of Psychiatry, 170, 549–553.
Weinstein, R. S. (1995) Panic disorder. American Family Physician, 52, 1999–2000, 2055–2063. 2067–2068.
Weissman, M. M. (1988) The epidemiology of panic disorder and agoraphobia. American Psychiatric Press Review of Psychiatry (Vol. 7) (eds Frances, A. J. & Hales, R. E.), pp. 54–66. Washington, DC: American Psychiatric Press.
et al (1996) Sertraline treatment of children and adolescents with obsessive compulsive disorder or depression. X World Congress of Psychiotry Abstracts, 2, 145.
Yeragani, V. K.
et al (1992) Imipramine-induced jitteriness and decreased serum iron levels. Neuropsychobiology, 25, 8–10.